Mandom Corp
TSE:4917
Mandom Corp
Operating Income
Mandom Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mandom Corp
TSE:4917
|
Operating Income
¥1.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-13%
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Income
¥16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
Kao Corp
TSE:4452
|
Operating Income
¥86.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥25.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Mandom Corp's Operating Income?
Operating Income
1.9B
JPY
Based on the financial report for Dec 31, 2023, Mandom Corp's Operating Income amounts to 1.9B JPY.
What is Mandom Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-13%
Over the last year, the Operating Income growth was 295%. The average annual Operating Income growth rates for Mandom Corp have been 23% over the past three years , -25% over the past five years , and -13% over the past ten years .